Methamphetamine/Stimulants Brief
Use of methamphetamine and other stimulants are on the rise and this is reflected in recent Virginia substance use indicators, including fatal overdoses from stimulants. This deliverable would describe the recent trends in stimulant use and what Virginia is doing to address these increases, such as the strategies covered by the expansion of the SOR grant to prioritize stimulants as a priority substance. Depending on interest and need, this deliverable could explore epidemiological trends related to the COVID-19 pandemic, geographic patterns across Virginia, higher risk subpopulations, and/or serve as an informational resource on methamphetamine and stimulants. This deliverable would serve as an information guide to ensure relevant stakeholders in the behavioral health and substance use fields are aware of the emerging need and strategies to address stimulant use.
Fentanyl Brief
Use of fentanyl has steadily increased in Virginia. The number of deaths per 100,000 people due to fentanyl has increased from 0.57 in 2011 to 8.58 in 2017. This deliverable would describe recent trends in fentanyl use and impacts within Virginia and ongoing and potential prevention efforts. Depending on interest and need, this deliverable could explore epidemiological trends related to the COVID-19 pandemic, geographic patterns across Virginia, and higher risk sThis deliverable will examine youth substance use trends across the state using Virginia Youth Survey 2019 data and previous years' data. The deliverable will also look at risk and protective factors and national data to paint a comprehensive picture of youth substance use and its context. This deliverable could be used to highlight the importance of prevention programs and addressing risk and protective factors among youth.